During the past decade, Texas Neurology PA conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 31 clinical trials were completed, i.e. on average, 93.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 20 clinical trials were completed. i.e. 181.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Neurology PA" #1 sponsor was "Cytokinetics" with 5 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Allergan" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Neurology PA" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "Leandro P. Rizzuto Foundation" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator and "Syneos Health" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Texas Neurology PA" are "Amyotrophic Lateral Sclerosis" (15 trials), "Alzheimer Disease" (7 trials), "Alzheimer's Disease" (7 trials), "ALS" (4 trials) and "Amyotrophic Lateral Sclerosis (ALS)" (2 trials). Many other conditions were trialed in "Texas Neurology PA" in a lesser frequency.

Most popular intervention types in "Texas Neurology PA" are "Drug" (51 trials), "Other" (5 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "placebo" (4 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "bapineuzumab" (3 trials) and "AMX0035" (2 trials). Other intervention names were less common.

The vast majority of trials in "Texas Neurology PA" are 54 trials for "All" genders.

Currently, there are NaN active trials in "Texas Neurology PA". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Texas Neurology PA, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Neurology PA, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".